Cargando…
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
Cancer is one of the diseases with high morbidity and mortality on a global scale. Chemotherapy remains the primary treatment option for most cancer patients, including patients with progressive, metastatic, and recurrent diseases. To date, hundreds of chemotherapy drugs are used to treat various ca...
Autores principales: | Liu, Xi, Xu, Jimin, Zhou, Jia, Shen, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209342/ https://www.ncbi.nlm.nih.gov/pubmed/34179309 http://dx.doi.org/10.1016/j.gendis.2020.06.010 |
Ejemplares similares
-
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection
por: Xu, Jimin, et al.
Publicado: (2018) -
Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling
por: Wang, Bili, et al.
Publicado: (2019) -
Oridonin improves the therapeutic effect of lentinan on lung cancer
por: Gui, Yun, et al.
Publicado: (2021) -
Recent advances in oridonin derivatives with anticancer activity
por: Sobral, Pedro J. M., et al.
Publicado: (2023) -
Molecular Insight in the Multifunctional Effects of Oridonin
por: Owona, Brice Ayissi, et al.
Publicado: (2015)